Exchange: NASDAQ·Updated 04:55 AM EDT
GNTA logo

GNTAGenenta Science SpA - ADR

$1.61
$0.03
(1.90%)
Pre-Market
Prev Close $1.58
Mkt Cap$37.02M
Vol2,810.00
News
all
press releases
News Placeholder
Genenta Stock Rises Pre-Market After Cell Therapy Improves Survival In Certain Tumor Patients
The company said that 25 patients have been treated with Temferon as of November 21, and 44% of glioblastoma multiforme patients have reached 18-month survival.
Stocktwits
News Placeholder
GNTA Stock Skyrockets 300% Pre-Market Toward Record Highs: What’s Driving The Super Rally?
Stocktwits
<
...
1
>

Advertisement|Remove ads.